Zonisamide

TypeName:
Business Offer
Request Date:
2017/06/23
Country:
United States
Summary:
AD-810; CI-912; PD-110843; 1,2-Benzisoxazole-3-methanesulfonamide; 3-(Sulfamoylmethyl)-1,2-benzisoxazole; Benzo[d]isoxazol-3-yl-methanesulfonamide
Description:
Zonisamide is a sulfonamide anticonvulsant approved for use as an adjunctive therapy in adults with partial-onset seizures, infantile spasm, mixed seizure types of Lennox–Gastaut syndrome, myoclonic, and generalized tonic clonic seizure.http://www.creative-peptides.com/product/zonisamide-item-10-101-130-124.html
Advantages:
Comments:
RequestId:
273
Name:
Cathy Miller
Telphone:
Categories

Countries

No Man flag

No Support in this time. please use Contact us form!